Compliance Rate
Compliance Rate
0%
Compliant submissions
0
Incompliant submissions
0
Total trials
0
My Organizations' Clinical Trials
Showing 2 of 2 entries
View as:
Phase: N/A
Priority: Normal
Start: 06/11/24
End: 12/01/30
Due: 12/01/31
Phase: N/A
Priority: Normal
Start: 06/20/24
End: 08/31/30
Due: 08/31/31
| Title | NCT ID | Organization | User | Status | Start Date | End Date | Reporting Due Date | Last Checked | User Role | Org Created |
|---|---|---|---|---|---|---|---|---|---|---|
| Study to Evaluate ACDN-01 in ABCA4-related Stargardt Retinopathy (STELLAR) | NCT06467344 | Ascidian Therapeutics, Inc | user2@example.com | None | 2024-06-11 | 2030-12-01 | 2031-12-01 | - | - | 2025-07-14 |
| Prescreening Study to Identify Potential Stargardt Participants for ACDN-01 Clinical Trials | NCT06445322 | Ascidian Therapeutics, Inc | user2@example.com | None | 2024-06-20 | 2030-08-31 | 2031-08-31 | - | - | 2025-07-14 |